Spero Therapeutics (SPRO – Research Report) received a Hold rating and price target from TD Cowen analyst Ritu Baral yesterday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback